Related Experiment Video
Updated: Jul 2, 2026

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
Published on: December 5, 2017
A review on herbal Nrf2 activators with preclinical evidence in cardiovascular diseases
Abu Mohammad Syed1, Chetan Ram1, Upadhyayula Suryanarayana Murty1
1Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Guwahati, Assam, India.
Abstract:
Cardiovascular diseases (CVDs) are an ever-growing problem and are the most common cause of death worldwide. The uncontrolled production of reactive oxygen species (ROS) and the activation of ROS associated with various cell signaling pathways with oxidative cellular damage are the most common pathological conditions connected with CVDs including endothelial dysfunction, hypercontractility of vascular smooth muscle, cardiac hypertrophy and heart failure. The nuclear factor E2-related factor 2 (Nrf2) is a basic leucine zipper redox transcription factor, together with its negative regulator, kelch-like ECH-associated protein 1 (Keap1), which serves as a key regulator of cellular defense mechanisms to combat oxidative stress and associated diseases. Multiple lines of evidence described here support the cardiac protective property of Nrf2 in various experimental models of cardiac related disease conditions. In this review, we emphasized the molecular mechanisms of Nrf2 and described the detailed outline of current findings on the therapeutic possibilities of the Nrf2 activators specifically from herbal origin in various CVDs. Based on evidence from various preclinical experimental models, we have highlighted the activation of Nrf2 pathway as a budding therapeutic option for the prevention and treatment of CVDs, which needs further investigation and validation in the clinical settings.
Insights
The nuclear factor E2-related factor 2 (Nrf2) pathway shows promise in protecting the heart from cardiovascular diseases (CVDs). Activating Nrf2, especially with herbal compounds, may offer new therapeutic strategies for CVDs.
Area of Science:
- Cardiovascular research
- Molecular biology
- Pharmacology
Background:
- Cardiovascular diseases (CVDs) are a leading global cause of death, often linked to oxidative stress and reactive oxygen species (ROS).
- Oxidative cellular damage contributes to pathological conditions like endothelial dysfunction, cardiac hypertrophy, and heart failure.
- The Nrf2-Keap1 pathway is a critical regulator of cellular defense against oxidative stress.
Purpose of the Study:
- To review the molecular mechanisms of Nrf2 in cardiovascular health.
- To explore the therapeutic potential of Nrf2 activators, particularly herbal compounds, for CVDs.
- To highlight Nrf2 activation as a potential therapeutic strategy for CVD prevention and treatment.
Main Methods:
- Literature review of experimental models of cardiac diseases.
- Analysis of molecular mechanisms underlying Nrf2's role in cardiovascular protection.
- Examination of findings on herbal Nrf2 activators in preclinical studies.
Main Results:
- Evidence supports the cardioprotective effects of Nrf2 in various experimental CVD models.
- Nrf2 activation mitigates oxidative stress and related cellular damage in the heart.
- Herbal compounds show potential in activating the Nrf2 pathway for therapeutic benefit.
Conclusions:
- The Nrf2 pathway is a significant target for combating oxidative stress in CVDs.
- Herbal-derived Nrf2 activators represent a promising therapeutic avenue for cardiovascular conditions.
- Further clinical validation of Nrf2 activation is needed for CVD treatment.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Nitric Oxide Signaling Pathway
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Cardiovascular Drugs: Classification based on Therapeutic Indications

